Global Neutropenia Biologic Drug Treatment Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Neutropenia Biologic Drug Treatment Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Neutropenia Biologic Drug Treatment by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Neutropenia Biologic Drug Treatment by Country/Region, 2017, 2022 & 2028

2.2 Neutropenia Biologic Drug Treatment Segment by Type

2.2.1 Filgrastim

2.2.2 Pegfilgrastim

2.2.3 Lenograstim

2.2.4 Lipegfilgrastim

2.2.5 Sargramostim

2.3 Neutropenia Biologic Drug Treatment Sales by Type

2.3.1 Global Neutropenia Biologic Drug Treatment Sales Market Share by Type (2017-2022)

2.3.2 Global Neutropenia Biologic Drug Treatment Revenue and Market Share by Type (2017-2022)

2.3.3 Global Neutropenia Biologic Drug Treatment Sale Price by Type (2017-2022)

2.4 Neutropenia Biologic Drug Treatment Segment by Application

2.4.1 Retail Pharmacies

2.4.2 Hospital Pharmacies

2.4.3 Online Pharmacies

2.5 Neutropenia Biologic Drug Treatment Sales by Application

2.5.1 Global Neutropenia Biologic Drug Treatment Sale Market Share by Application (2017-2022)

2.5.2 Global Neutropenia Biologic Drug Treatment Revenue and Market Share by Application (2017-2022)

2.5.3 Global Neutropenia Biologic Drug Treatment Sale Price by Application (2017-2022)

3 Global Neutropenia Biologic Drug Treatment by Company

3.1 Global Neutropenia Biologic Drug Treatment Breakdown Data by Company

3.1.1 Global Neutropenia Biologic Drug Treatment Annual Sales by Company (2020-2022)

3.1.2 Global Neutropenia Biologic Drug Treatment Sales Market Share by Company (2020-2022)

3.2 Global Neutropenia Biologic Drug Treatment Annual Revenue by Company (2020-2022)

3.2.1 Global Neutropenia Biologic Drug Treatment Revenue by Company (2020-2022)

3.2.2 Global Neutropenia Biologic Drug Treatment Revenue Market Share by Company (2020-2022)

3.3 Global Neutropenia Biologic Drug Treatment Sale Price by Company

3.4 Key Manufacturers Neutropenia Biologic Drug Treatment Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Neutropenia Biologic Drug Treatment Product Location Distribution

3.4.2 Players Neutropenia Biologic Drug Treatment Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Neutropenia Biologic Drug Treatment by Geographic Region

4.1 World Historic Neutropenia Biologic Drug Treatment Market Size by Geographic Region (2017-2022)

4.1.1 Global Neutropenia Biologic Drug Treatment Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Neutropenia Biologic Drug Treatment Annual Revenue by Geographic Region

4.2 World Historic Neutropenia Biologic Drug Treatment Market Size by Country/Region (2017-2022)

4.2.1 Global Neutropenia Biologic Drug Treatment Annual Sales by Country/Region (2017-2022)

4.2.2 Global Neutropenia Biologic Drug Treatment Annual Revenue by Country/Region

4.3 Americas Neutropenia Biologic Drug Treatment Sales Growth

4.4 APAC Neutropenia Biologic Drug Treatment Sales Growth

4.5 Europe Neutropenia Biologic Drug Treatment Sales Growth

4.6 Middle East & Africa Neutropenia Biologic Drug Treatment Sales Growth

5 Americas

5.1 Americas Neutropenia Biologic Drug Treatment Sales by Country

5.1.1 Americas Neutropenia Biologic Drug Treatment Sales by Country (2017-2022)

5.1.2 Americas Neutropenia Biologic Drug Treatment Revenue by Country (2017-2022)

5.2 Americas Neutropenia Biologic Drug Treatment Sales by Type

5.3 Americas Neutropenia Biologic Drug Treatment Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Neutropenia Biologic Drug Treatment Sales by Region

6.1.1 APAC Neutropenia Biologic Drug Treatment Sales by Region (2017-2022)

6.1.2 APAC Neutropenia Biologic Drug Treatment Revenue by Region (2017-2022)

6.2 APAC Neutropenia Biologic Drug Treatment Sales by Type

6.3 APAC Neutropenia Biologic Drug Treatment Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Neutropenia Biologic Drug Treatment by Country

7.1.1 Europe Neutropenia Biologic Drug Treatment Sales by Country (2017-2022)

7.1.2 Europe Neutropenia Biologic Drug Treatment Revenue by Country (2017-2022)

7.2 Europe Neutropenia Biologic Drug Treatment Sales by Type

7.3 Europe Neutropenia Biologic Drug Treatment Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Neutropenia Biologic Drug Treatment by Country

8.1.1 Middle East & Africa Neutropenia Biologic Drug Treatment Sales by Country (2017-2022)

8.1.2 Middle East & Africa Neutropenia Biologic Drug Treatment Revenue by Country (2017-2022)

8.2 Middle East & Africa Neutropenia Biologic Drug Treatment Sales by Type

8.3 Middle East & Africa Neutropenia Biologic Drug Treatment Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Neutropenia Biologic Drug Treatment

10.3 Manufacturing Process Analysis of Neutropenia Biologic Drug Treatment

10.4 Industry Chain Structure of Neutropenia Biologic Drug Treatment

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Neutropenia Biologic Drug Treatment Distributors

11.3 Neutropenia Biologic Drug Treatment Customer

12 World Forecast Review for Neutropenia Biologic Drug Treatment by Geographic Region

12.1 Global Neutropenia Biologic Drug Treatment Market Size Forecast by Region

12.1.1 Global Neutropenia Biologic Drug Treatment Forecast by Region (2023-2028)

12.1.2 Global Neutropenia Biologic Drug Treatment Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Neutropenia Biologic Drug Treatment Forecast by Type

12.7 Global Neutropenia Biologic Drug Treatment Forecast by Application

13 Key Players Analysis

13.1 Amgen

13.1.1 Amgen Company Information

13.1.2 Amgen Neutropenia Biologic Drug Treatment Product Offered

13.1.3 Amgen Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Amgen Main Business Overview

13.1.5 Amgen Latest Developments

13.2 Novartis

13.2.1 Novartis Company Information

13.2.2 Novartis Neutropenia Biologic Drug Treatment Product Offered

13.2.3 Novartis Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Novartis Main Business Overview

13.2.5 Novartis Latest Developments

13.3 Pfizer

13.3.1 Pfizer Company Information

13.3.2 Pfizer Neutropenia Biologic Drug Treatment Product Offered

13.3.3 Pfizer Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Pfizer Main Business Overview

13.3.5 Pfizer Latest Developments

13.4 Baxter International

13.4.1 Baxter International Company Information

13.4.2 Baxter International Neutropenia Biologic Drug Treatment Product Offered

13.4.3 Baxter International Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Baxter International Main Business Overview

13.4.5 Baxter International Latest Developments

13.5 Cellerant Therapeutics

13.5.1 Cellerant Therapeutics Company Information

13.5.2 Cellerant Therapeutics Neutropenia Biologic Drug Treatment Product Offered

13.5.3 Cellerant Therapeutics Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Cellerant Therapeutics Main Business Overview

13.5.5 Cellerant Therapeutics Latest Developments

13.6 Dong-A ST Co.,Ltd.

13.6.1 Dong-A ST Co.,Ltd. Company Information

13.6.2 Dong-A ST Co.,Ltd. Neutropenia Biologic Drug Treatment Product Offered

13.6.3 Dong-A ST Co.,Ltd. Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Dong-A ST Co.,Ltd. Main Business Overview

13.6.5 Dong-A ST Co.,Ltd. Latest Developments

13.7 Myelo Therapeutics GmbH

13.7.1 Myelo Therapeutics GmbH Company Information

13.7.2 Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Product Offered

13.7.3 Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Myelo Therapeutics GmbH Main Business Overview

13.7.5 Myelo Therapeutics GmbH Latest Developments

13.8 Sanofi

13.8.1 Sanofi Company Information

13.8.2 Sanofi Neutropenia Biologic Drug Treatment Product Offered

13.8.3 Sanofi Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Sanofi Main Business Overview

13.8.5 Sanofi Latest Developments

13.9 Teva Pharmaceutical Industries Ltd.

13.9.1 Teva Pharmaceutical Industries Ltd. Company Information

13.9.2 Teva Pharmaceutical Industries Ltd. Neutropenia Biologic Drug Treatment Product Offered

13.9.3 Teva Pharmaceutical Industries Ltd. Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Teva Pharmaceutical Industries Ltd. Main Business Overview

13.9.5 Teva Pharmaceutical Industries Ltd. Latest Developments

13.10 Kyowa Kirin

13.10.1 Kyowa Kirin Company Information

13.10.2 Kyowa Kirin Neutropenia Biologic Drug Treatment Product Offered

13.10.3 Kyowa Kirin Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Kyowa Kirin Main Business Overview

13.10.5 Kyowa Kirin Latest Developments

13.11 CVS Health

13.11.1 CVS Health Company Information

13.11.2 CVS Health Neutropenia Biologic Drug Treatment Product Offered

13.11.3 CVS Health Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 CVS Health Main Business Overview

13.11.5 CVS Health Latest Developments

13.12 Partner Therapeutics

13.12.1 Partner Therapeutics Company Information

13.12.2 Partner Therapeutics Neutropenia Biologic Drug Treatment Product Offered

13.12.3 Partner Therapeutics Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Partner Therapeutics Main Business Overview

13.12.5 Partner Therapeutics Latest Developments

13.13 Enzychem Lifesciences Corporation

13.13.1 Enzychem Lifesciences Corporation Company Information

13.13.2 Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Product Offered

13.13.3 Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Enzychem Lifesciences Corporation Main Business Overview

13.13.5 Enzychem Lifesciences Corporation Latest Developments

14 Research Findings and Conclusion

Table 1. Neutropenia Biologic Drug Treatment Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Neutropenia Biologic Drug Treatment Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Filgrastim

Table 4. Major Players of Pegfilgrastim

Table 5. Major Players of Lenograstim

Table 6. Major Players of Lipegfilgrastim

Table 7. Major Players of Sargramostim

Table 8. Global Neutropenia Biologic Drug Treatment Sales by Type (2017-2022) & (K Units)

Table 9. Global Neutropenia Biologic Drug Treatment Sales Market Share by Type (2017-2022)

Table 10. Global Neutropenia Biologic Drug Treatment Revenue by Type (2017-2022) & ($ million)

Table 11. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Type (2017-2022)

Table 12. Global Neutropenia Biologic Drug Treatment Sale Price by Type (2017-2022) & (US$/Unit)

Table 13. Global Neutropenia Biologic Drug Treatment Sales by Application (2017-2022) & (K Units)

Table 14. Global Neutropenia Biologic Drug Treatment Sales Market Share by Application (2017-2022)

Table 15. Global Neutropenia Biologic Drug Treatment Revenue by Application (2017-2022)

Table 16. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Application (2017-2022)

Table 17. Global Neutropenia Biologic Drug Treatment Sale Price by Application (2017-2022) & (US$/Unit)

Table 18. Global Neutropenia Biologic Drug Treatment Sales by Company (2020-2022) & (K Units)

Table 19. Global Neutropenia Biologic Drug Treatment Sales Market Share by Company (2020-2022)

Table 20. Global Neutropenia Biologic Drug Treatment Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Company (2020-2022)

Table 22. Global Neutropenia Biologic Drug Treatment Sale Price by Company (2020-2022) & (US$/Unit)

Table 23. Key Manufacturers Neutropenia Biologic Drug Treatment Producing Area Distribution and Sales Area

Table 24. Players Neutropenia Biologic Drug Treatment Products Offered

Table 25. Neutropenia Biologic Drug Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Neutropenia Biologic Drug Treatment Sales by Geographic Region (2017-2022) & (K Units)

Table 29. Global Neutropenia Biologic Drug Treatment Sales Market Share Geographic Region (2017-2022)

Table 30. Global Neutropenia Biologic Drug Treatment Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Neutropenia Biologic Drug Treatment Sales by Country/Region (2017-2022) & (K Units)

Table 33. Global Neutropenia Biologic Drug Treatment Sales Market Share by Country/Region (2017-2022)

Table 34. Global Neutropenia Biologic Drug Treatment Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Neutropenia Biologic Drug Treatment Sales by Country (2017-2022) & (K Units)

Table 37. Americas Neutropenia Biologic Drug Treatment Sales Market Share by Country (2017-2022)

Table 38. Americas Neutropenia Biologic Drug Treatment Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Neutropenia Biologic Drug Treatment Revenue Market Share by Country (2017-2022)

Table 40. Americas Neutropenia Biologic Drug Treatment Sales by Type (2017-2022) & (K Units)

Table 41. Americas Neutropenia Biologic Drug Treatment Sales Market Share by Type (2017-2022)

Table 42. Americas Neutropenia Biologic Drug Treatment Sales by Application (2017-2022) & (K Units)

Table 43. Americas Neutropenia Biologic Drug Treatment Sales Market Share by Application (2017-2022)

Table 44. APAC Neutropenia Biologic Drug Treatment Sales by Region (2017-2022) & (K Units)

Table 45. APAC Neutropenia Biologic Drug Treatment Sales Market Share by Region (2017-2022)

Table 46. APAC Neutropenia Biologic Drug Treatment Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Neutropenia Biologic Drug Treatment Revenue Market Share by Region (2017-2022)

Table 48. APAC Neutropenia Biologic Drug Treatment Sales by Type (2017-2022) & (K Units)

Table 49. APAC Neutropenia Biologic Drug Treatment Sales Market Share by Type (2017-2022)

Table 50. APAC Neutropenia Biologic Drug Treatment Sales by Application (2017-2022) & (K Units)

Table 51. APAC Neutropenia Biologic Drug Treatment Sales Market Share by Application (2017-2022)

Table 52. Europe Neutropenia Biologic Drug Treatment Sales by Country (2017-2022) & (K Units)

Table 53. Europe Neutropenia Biologic Drug Treatment Sales Market Share by Country (2017-2022)

Table 54. Europe Neutropenia Biologic Drug Treatment Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Neutropenia Biologic Drug Treatment Revenue Market Share by Country (2017-2022)

Table 56. Europe Neutropenia Biologic Drug Treatment Sales by Type (2017-2022) & (K Units)

Table 57. Europe Neutropenia Biologic Drug Treatment Sales Market Share by Type (2017-2022)

Table 58. Europe Neutropenia Biologic Drug Treatment Sales by Application (2017-2022) & (K Units)

Table 59. Europe Neutropenia Biologic Drug Treatment Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Neutropenia Biologic Drug Treatment Sales by Country (2017-2022) & (K Units)

Table 61. Middle East & Africa Neutropenia Biologic Drug Treatment Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Neutropenia Biologic Drug Treatment Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Neutropenia Biologic Drug Treatment Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Neutropenia Biologic Drug Treatment Sales by Type (2017-2022) & (K Units)

Table 65. Middle East & Africa Neutropenia Biologic Drug Treatment Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Neutropenia Biologic Drug Treatment Sales by Application (2017-2022) & (K Units)

Table 67. Middle East & Africa Neutropenia Biologic Drug Treatment Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Neutropenia Biologic Drug Treatment

Table 69. Key Market Challenges & Risks of Neutropenia Biologic Drug Treatment

Table 70. Key Industry Trends of Neutropenia Biologic Drug Treatment

Table 71. Neutropenia Biologic Drug Treatment Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Neutropenia Biologic Drug Treatment Distributors List

Table 74. Neutropenia Biologic Drug Treatment Customer List

Table 75. Global Neutropenia Biologic Drug Treatment Sales Forecast by Region (2023-2028) & (K Units)

Table 76. Global Neutropenia Biologic Drug Treatment Sales Market Forecast by Region

Table 77. Global Neutropenia Biologic Drug Treatment Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Neutropenia Biologic Drug Treatment Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Neutropenia Biologic Drug Treatment Sales Forecast by Country (2023-2028) & (K Units)

Table 80. Americas Neutropenia Biologic Drug Treatment Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Neutropenia Biologic Drug Treatment Sales Forecast by Region (2023-2028) & (K Units)

Table 82. APAC Neutropenia Biologic Drug Treatment Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Neutropenia Biologic Drug Treatment Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Europe Neutropenia Biologic Drug Treatment Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Neutropenia Biologic Drug Treatment Sales Forecast by Country (2023-2028) & (K Units)

Table 86. Middle East & Africa Neutropenia Biologic Drug Treatment Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Neutropenia Biologic Drug Treatment Sales Forecast by Type (2023-2028) & (K Units)

Table 88. Global Neutropenia Biologic Drug Treatment Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Neutropenia Biologic Drug Treatment Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Neutropenia Biologic Drug Treatment Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Neutropenia Biologic Drug Treatment Sales Forecast by Application (2023-2028) & (K Units)

Table 92. Global Neutropenia Biologic Drug Treatment Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Neutropenia Biologic Drug Treatment Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Neutropenia Biologic Drug Treatment Revenue Market Share Forecast by Application (2023-2028)

Table 95. Amgen Basic Information, Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors

Table 96. Amgen Neutropenia Biologic Drug Treatment Product Offered

Table 97. Amgen Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 98. Amgen Main Business

Table 99. Amgen Latest Developments

Table 100. Novartis Basic Information, Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors

Table 101. Novartis Neutropenia Biologic Drug Treatment Product Offered

Table 102. Novartis Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 103. Novartis Main Business

Table 104. Novartis Latest Developments

Table 105. Pfizer Basic Information, Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors

Table 106. Pfizer Neutropenia Biologic Drug Treatment Product Offered

Table 107. Pfizer Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 108. Pfizer Main Business

Table 109. Pfizer Latest Developments

Table 110. Baxter International Basic Information, Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors

Table 111. Baxter International Neutropenia Biologic Drug Treatment Product Offered

Table 112. Baxter International Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 113. Baxter International Main Business

Table 114. Baxter International Latest Developments

Table 115. Cellerant Therapeutics Basic Information, Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors

Table 116. Cellerant Therapeutics Neutropenia Biologic Drug Treatment Product Offered

Table 117. Cellerant Therapeutics Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 118. Cellerant Therapeutics Main Business

Table 119. Cellerant Therapeutics Latest Developments

Table 120. Dong-A ST Co.,Ltd. Basic Information, Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors

Table 121. Dong-A ST Co.,Ltd. Neutropenia Biologic Drug Treatment Product Offered

Table 122. Dong-A ST Co.,Ltd. Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 123. Dong-A ST Co.,Ltd. Main Business

Table 124. Dong-A ST Co.,Ltd. Latest Developments

Table 125. Myelo Therapeutics GmbH Basic Information, Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors

Table 126. Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Product Offered

Table 127. Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 128. Myelo Therapeutics GmbH Main Business

Table 129. Myelo Therapeutics GmbH Latest Developments

Table 130. Sanofi Basic Information, Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors

Table 131. Sanofi Neutropenia Biologic Drug Treatment Product Offered

Table 132. Sanofi Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 133. Sanofi Main Business

Table 134. Sanofi Latest Developments

Table 135. Teva Pharmaceutical Industries Ltd. Basic Information, Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors

Table 136. Teva Pharmaceutical Industries Ltd. Neutropenia Biologic Drug Treatment Product Offered

Table 137. Teva Pharmaceutical Industries Ltd. Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 138. Teva Pharmaceutical Industries Ltd. Main Business

Table 139. Teva Pharmaceutical Industries Ltd. Latest Developments

Table 140. Kyowa Kirin Basic Information, Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors

Table 141. Kyowa Kirin Neutropenia Biologic Drug Treatment Product Offered

Table 142. Kyowa Kirin Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 143. Kyowa Kirin Main Business

Table 144. Kyowa Kirin Latest Developments

Table 145. CVS Health Basic Information, Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors

Table 146. CVS Health Neutropenia Biologic Drug Treatment Product Offered

Table 147. CVS Health Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 148. CVS Health Main Business

Table 149. CVS Health Latest Developments

Table 150. Partner Therapeutics Basic Information, Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors

Table 151. Partner Therapeutics Neutropenia Biologic Drug Treatment Product Offered

Table 152. Partner Therapeutics Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 153. Partner Therapeutics Main Business

Table 154. Partner Therapeutics Latest Developments

Table 155. Enzychem Lifesciences Corporation Basic Information, Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors

Table 156. Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Product Offered

Table 157. Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 158. Enzychem Lifesciences Corporation Main Business

Table 159. Enzychem Lifesciences Corporation Latest Developments

List of Figures

Figure 1. Picture of Neutropenia Biologic Drug Treatment

Figure 2. Neutropenia Biologic Drug Treatment Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Neutropenia Biologic Drug Treatment Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Neutropenia Biologic Drug Treatment Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Neutropenia Biologic Drug Treatment Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Filgrastim

Figure 10. Product Picture of Pegfilgrastim

Figure 11. Product Picture of Lenograstim

Figure 12. Product Picture of Lipegfilgrastim

Figure 13. Product Picture of Sargramostim

Figure 14. Global Neutropenia Biologic Drug Treatment Sales Market Share by Type in 2021

Figure 15. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Type (2017-2022)

Figure 16. Neutropenia Biologic Drug Treatment Consumed in Retail Pharmacies

Figure 17. Global Neutropenia Biologic Drug Treatment Market: Retail Pharmacies (2017-2022) & (K Units)

Figure 18. Neutropenia Biologic Drug Treatment Consumed in Hospital Pharmacies

Figure 19. Global Neutropenia Biologic Drug Treatment Market: Hospital Pharmacies (2017-2022) & (K Units)

Figure 20. Neutropenia Biologic Drug Treatment Consumed in Online Pharmacies

Figure 21. Global Neutropenia Biologic Drug Treatment Market: Online Pharmacies (2017-2022) & (K Units)

Figure 22. Global Neutropenia Biologic Drug Treatment Sales Market Share by Application (2017-2022)

Figure 23. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Application in 2021

Figure 24. Neutropenia Biologic Drug Treatment Revenue Market by Company in 2021 ($ Million)

Figure 25. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Company in 2021

Figure 26. Global Neutropenia Biologic Drug Treatment Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Geographic Region in 2021

Figure 28. Global Neutropenia Biologic Drug Treatment Sales Market Share by Region (2017-2022)

Figure 29. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Country/Region in 2021

Figure 30. Americas Neutropenia Biologic Drug Treatment Sales 2017-2022 (K Units)

Figure 31. Americas Neutropenia Biologic Drug Treatment Revenue 2017-2022 ($ Millions)

Figure 32. APAC Neutropenia Biologic Drug Treatment Sales 2017-2022 (K Units)

Figure 33. APAC Neutropenia Biologic Drug Treatment Revenue 2017-2022 ($ Millions)

Figure 34. Europe Neutropenia Biologic Drug Treatment Sales 2017-2022 (K Units)

Figure 35. Europe Neutropenia Biologic Drug Treatment Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa Neutropenia Biologic Drug Treatment Sales 2017-2022 (K Units)

Figure 37. Middle East & Africa Neutropenia Biologic Drug Treatment Revenue 2017-2022 ($ Millions)

Figure 38. Americas Neutropenia Biologic Drug Treatment Sales Market Share by Country in 2021

Figure 39. Americas Neutropenia Biologic Drug Treatment Revenue Market Share by Country in 2021

Figure 40. United States Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC Neutropenia Biologic Drug Treatment Sales Market Share by Region in 2021

Figure 45. APAC Neutropenia Biologic Drug Treatment Revenue Market Share by Regions in 2021

Figure 46. China Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 50. India Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe Neutropenia Biologic Drug Treatment Sales Market Share by Country in 2021

Figure 53. Europe Neutropenia Biologic Drug Treatment Revenue Market Share by Country in 2021

Figure 54. Germany Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 55. France Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa Neutropenia Biologic Drug Treatment Sales Market Share by Country in 2021

Figure 60. Middle East & Africa Neutropenia Biologic Drug Treatment Revenue Market Share by Country in 2021

Figure 61. Egypt Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country Neutropenia Biologic Drug Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of Neutropenia Biologic Drug Treatment in 2021

Figure 67. Manufacturing Process Analysis of Neutropenia Biologic Drug Treatment

Figure 68. Industry Chain Structure of Neutropenia Biologic Drug Treatment

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles